AR028281A1 - DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA - Google Patents

DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA

Info

Publication number
AR028281A1
AR028281A1 ARP010101373A ARP010101373A AR028281A1 AR 028281 A1 AR028281 A1 AR 028281A1 AR P010101373 A ARP010101373 A AR P010101373A AR P010101373 A ARP010101373 A AR P010101373A AR 028281 A1 AR028281 A1 AR 028281A1
Authority
AR
Argentina
Prior art keywords
pirimidona
derivatives
heteroaroarilalquilamino
arilalquilamino
Prior art date
Application number
ARP010101373A
Other languages
Spanish (es)
Original Assignee
Sanofi Synthelabo
Mitsubishi Tokyo Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00400805A external-priority patent/EP1136099A1/en
Priority claimed from EP00400806A external-priority patent/EP1136491A1/en
Priority claimed from EP00400804A external-priority patent/EP1136484A1/en
Priority claimed from JP2000081938A external-priority patent/JP2001270884A/en
Application filed by Sanofi Synthelabo, Mitsubishi Tokyo Pharm Inc filed Critical Sanofi Synthelabo
Publication of AR028281A1 publication Critical patent/AR028281A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010101373A 2000-03-23 2001-03-23 DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA AR028281A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00400805A EP1136099A1 (en) 2000-03-23 2000-03-23 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors
EP00400806A EP1136491A1 (en) 2000-03-23 2000-03-23 2-[(Heteroaryl)alkylamino]pyrimidone derivatives
EP00400804A EP1136484A1 (en) 2000-03-23 2000-03-23 2-(Arylalkylamino)pyrimidone derivatives
JP2000081938A JP2001270884A (en) 2000-03-23 2000-03-23 Pyrimidone derivative

Publications (1)

Publication Number Publication Date
AR028281A1 true AR028281A1 (en) 2003-04-30

Family

ID=27440051

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101373A AR028281A1 (en) 2000-03-23 2001-03-23 DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA

Country Status (3)

Country Link
AR (1) AR028281A1 (en)
AU (1) AU2001248365A1 (en)
WO (1) WO2001070727A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284712T1 (en) 2000-04-26 2005-01-15 Eisai Co Ltd MEDICINAL COMPOSITIONS FOR PROMOTING VITAL ACTIVATION
TWI335221B (en) * 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
TWI301834B (en) * 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
TWI330183B (en) 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
AU2003220026A1 (en) * 2002-03-01 2003-09-16 Chiron Corporation Methods and compositions for the treatment of ischemia
EP1925306A3 (en) * 2002-04-30 2008-09-17 Alcon, Inc. Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure
AU2003221762B2 (en) 2002-04-30 2008-09-25 Alcon, Inc. Agents which regulate, inhibit or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
EP1556355A1 (en) 2002-10-21 2005-07-27 Chiron Corporation Inhibitors of glycogen synthase kinase 3
WO2005076854A2 (en) * 2004-02-04 2005-08-25 Smithkline Beecham Corporation Pyrimidinone compounds useful as kinase inhibitors
AP2007004095A0 (en) 2005-01-07 2007-08-31 Univ Emory Cxcr4 antagonists for the treatment of hiv infection
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (en) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド Neurogenesis by angiotensin regulation
JP2009543802A (en) * 2006-07-11 2009-12-10 エモリー・ユニバーシテイ CXCR4 antagonists containing diazine and triazine structures for the treatment of medical diseases
EP2043633B1 (en) * 2006-07-18 2016-07-06 University of Rochester Thiadiazolidinone derivatives for treating cancer
JP2010501540A (en) * 2006-08-23 2010-01-21 ファイザー・プロダクツ・インク Pyrimidone compounds as GSK-3 inhibitors
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009058216A1 (en) * 2007-11-01 2009-05-07 Acucela, Inc. Amine derivative compounds for treating ophthalmic diseases and disorders
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW520362B (en) * 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same

Also Published As

Publication number Publication date
WO2001070727A1 (en) 2001-09-27
AU2001248365A1 (en) 2001-10-03

Similar Documents

Publication Publication Date Title
AR028281A1 (en) DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA
AR028567A1 (en) NEW DERIVATIVES OF FENIL-PROPARGILETER
AR028596A1 (en) NEW DERIVATIVES OF PHENYLGLYCIN
NO20025978D0 (en) Benzothiazole derivatives
ID30590A (en) ONCE USE SHORT TYPE OF SHORT-PANTS
AR028253A1 (en) INHIBITORS OF THE GLUCOGENO FOSFORILASA
AR028343A1 (en) PIRROLIDINE AND PIPERIDINE DERIVATIVES
AR027938A1 (en) URACILO COMPOUNDS AND USE OF THE SAME
DE60134338D1 (en) PIPERAZIN DERIVATIVES
DK1292604T3 (en) 2-aminocarbonyl-9H-purine derivatives
DE60043343D1 (en) CHROME DERIVATIVES
DE50112013D1 (en) DEODORANTIA AND ANTIPERSPIRANTIES
ID30187A (en) DONGKRAK KIND OF PANTAGRAF
ATE298332T1 (en) DECAHYDRO-ISOCHINOLINE DERIVATIVES
DK1280809T3 (en) Antitumorecteinascidin derivatives
AR028602A1 (en) PIRROL DERIVATIVES
PT1246817E (en) DERIVATIVES OF 4-PHENYL-1-PIPERAZINYL, -PIPERIDINYL E-TETRAHYDROPYRIDYL
PT1322592E (en) SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL
DE60032898D1 (en) ARYLTHIAZOLIDEINDION AND ARYLOXAZOLIDINE DERIVATIVES
PT1351959E (en) NEW PLEUROMUTILINE DERIVATIVES
DE60117096D1 (en) DIHYDROINDOL AND TETRAHYDROCHINOLINE DERIVATIVES
DK1246791T3 (en) Aminomethyl-phenyl-cyclohexanone derivatives
PT1392670E (en) SUBSTITUTED DERIVATIVES OF C-FURAN-2-IL-METHYLAMINE AND C-THIOFEN-2-IL-METHYLAMINE
AR027964A1 (en) COMBINATION OF THERMOPLASTIC EPNXIC FIBERS AND DERIVATIVES
DE60007360D1 (en) AMORPHE MODIFICATION OF TORASEMID

Legal Events

Date Code Title Description
FB Suspension of granting procedure